Literature DB >> 18645088

Applications of Gore-Tex implants in rhinoplasty reexamined after 17 years.

Krzysztof Conrad1, Cory Stephen Torgerson, Grant S Gillman.   

Abstract

OBJECTIVE: To determine the efficacy of GORE-TEX (W. L. Gore & Associates Inc, Flagstaff, Arizona) alloplast in rhinoplasty.
DESIGN: A 17-year retrospective medical chart review at a teaching hospital, community hospital, and private facial cosmetic surgery center. A total of 521 patients (122 male and 399 female; age range, 13-70 years) were followed for 12 months to 17 years. All patients had undergone GORE-TEX implantation rhinoplasty (685 implants in 158 primary procedures and 508 secondary procedures) performed by 1 surgeon. Patient satisfaction, expressed with respect to desired cosmetic benefit and functional outcome, and physician assessment, based on aesthetic improvement, technical considerations, and complications, were evaluated. Results were assessed according to the follow-up notes in the medical chart reflecting patients' and surgeon's comments and full preoperative and postoperative photographic documentation.
RESULTS: GORE-TEX alloplasts, 1 to 10 mm thick, implanted in the nasal dorsum (n = 264), lateral nasal wall (n = 252), supratip dorsum (n = 85), and premaxilla (n = 84) showed excellent stability and tissue tolerance. Biological complications that required implant removal occurred in 1.9% of patients and included infection, soft tissue swelling, migration, and extrusion.
CONCLUSIONS: With the exception of the nasal tip, columella, or problems in which corrections would require rigidity of the grafted or implanted material, the GORE-TEX alloplast is a safe, inexpensive, and predictable alternative to autografts. In the present series, more than 95% of implants used were 1 to 4 mm thick. In the remaining 5%, 6 implants ranged from 8 to 10 mm thick, and we found them acceptable. It is our opinion that for both primary and secondary rhinoplasty with adequate endonasal and external soft tissue coverage, GORE-TEX should be strongly considered for major and minor corrections of the nasal wall and bridge in properly selected patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18645088     DOI: 10.1001/archfaci.10.4.224

Source DB:  PubMed          Journal:  Arch Facial Plast Surg        ISSN: 1521-2491


  7 in total

Review 1.  Imaging features of rhinoplasty.

Authors:  C J Schatz; D T Ginat
Journal:  AJNR Am J Neuroradiol       Date:  2013-01-10       Impact factor: 3.825

2.  Treatment of Infected Facial Implants.

Authors:  Kriti Mohan; Joshua A Cox; Ryan M Dickey; Paula Gravina; Anthony Echo; Shayan A Izaddoost; Anh H Nguyen
Journal:  Semin Plast Surg       Date:  2016-05       Impact factor: 2.314

3.  Revisiting the Use of GORE-TEX as an Interpositional Material in Surgical Management of Severe Temporomandibular Joint Ankylosis.

Authors:  Girish S Mishra; Jaykumar V Patel
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2020-01-20

Review 4.  Imaging of cosmetic facial implants and grafts.

Authors:  C J Schatz; D T Ginat
Journal:  AJNR Am J Neuroradiol       Date:  2012-08-09       Impact factor: 3.825

5.  Augmentation rhinoplasty with custom-made S-shape silicone implant in Asians: A 15-year experience.

Authors:  Apirag Chuangsuwanich; Visnu Lohsiriwat
Journal:  Indian J Plast Surg       Date:  2013-09

Review 6.  Prevalence of complications associated with polymer-based alloplastic materials in nasal dorsal augmentation: a systematic review and meta-analysis.

Authors:  Seied Omid Keyhan; Shaqayeq Ramezanzade; Reza Golvardi Yazdi; Mohammad Amin Valipour; Hamid Reza Fallahi; Madjid Shakiba; Mahsa Aeinehvand
Journal:  Maxillofac Plast Reconstr Surg       Date:  2022-04-22

7.  Safety and Efficacy of Cosmetic Augmentation of the Nasal Tip and Nasal Dorsum With Expanded Polytetrafluoroethylene: A Randomized Clinical Trial.

Authors:  Yifei Gu; Wenxin Yu; Yunbo Jin; Hui Chen; Gang Ma; Shih-Jen Chang; Xiaoxi Lin
Journal:  JAMA Facial Plast Surg       Date:  2018-07-01       Impact factor: 4.611

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.